Can molecular subtyping be used to guide metastatic screening in breast cancer?
Am J Clin Pathol
.
2015 Apr;143(4):468-70.
doi: 10.1309/AJCPR3BFA2PHSNYD.
Authors
Siobhan M O'Connor
1
,
Thomas J Lawton
1
Affiliation
1
From the Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill.
PMID:
25779996
DOI:
10.1309/AJCPR3BFA2PHSNYD
No abstract available
Publication types
Editorial
Comment
MeSH terms
Bone Neoplasms / secondary*
Brain Neoplasms / secondary*
Breast Neoplasms / pathology*
Female
Humans
Liver Neoplasms / secondary*
Lung Neoplasms / secondary*